Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
Main Article Content
Keywords
Vancomycin, Pharmacokinetics, TDM, Volume of distribution (Vd), Critically ill patients, AKI
Abstract
-
Downloads
References
2. Ghasemiyeh P, Vazin A, and Mohammadi-Samani S. A brief review of pharmacokinetic assessments of vancomycin in special groups of patients with altered pharmacokinetic parameters. Curr Drug Saf. 2023 Nov 1;18(4):425-439. doi: 10.2174/1574886317666220801124718.
3. Gibaldi M and Perrier D. Apparent volume of distribution. In: Pharmacokinetics. New York: Wiley Online Library; 2007. p. 199-208.
4. Beringer P. Vancomycin. In: Winter's Basic Clinical Pharmacokinetics. Philadelphia: Wolters Kluwer; 2018. p. 467-496.
5. Coté CJ, Lerman J, and Anderson BJ. Pharmacokinetics and Pharmacology of Drugs Used in Children. In: A Practice of Anesthesia for Infants and Children. Auckland, New Zealand: Elsevier; 2018. p. 482-485.
6. Vondracek SF, Teitelbaum I, and Kiser TH. Principles of kidney pharmacotherapy for the nephrologist: Core curriculum 2021. Am J Kidney Dis. 2021;78(3):442-458. doi: 10.1053/j.ajkd.2021.02.342.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
